Promising brain tumor treatment study halted before it began
Disease control
Terminated
This study aimed to test a new way to treat brain tumors that came back after standard therapy. The plan was to deliver immunotherapy (nivolumab) plus chemotherapy directly into the fluid spaces of the brain in children and adults. However, the study was withdrawn before any part…
Phase: PHASE1 • Sponsor: Jeffrey Treiber • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC